Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129740
Status:
COMPLETED
Last Update Posted:
2019-09-24
First Post:
2005-08-11
Brief Title:
Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia CML
Sponsor:
Organization:
MD Anderson Cancer Center